TMXXF Financial Statements & Analysis
Complete financial statements for TMXXF including income statement, balance sheet, and cash flow statement. Analyze TMXXF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
17.6% ↑
Net Income
-13.7% ↓
Gross Margin
-0.2% ↓
Operating Margin
2.1% ↑
Balance Sheet
Current Ratio
-0.6% ↓
Debt to Equity
-4.0% ↑
Asset Turnover
-6.8% ↓
Cash Flow
Operating Cash Flow
10.2% ↑
Net Cash Flow
191.3% ↑
Free Cash Flow
17.1% ↑
Cash Flow to Debt
10.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 1.46B | 1.72B | 17.6% | |
| Gross Profit | 958.80M | 1.13B | 17.4% | |
| Operating Income | 642.30M | 771.00M | 20.0% | |
| Net Income | 481.50M | 415.70M | 13.7% | |
| EPS | 1.74 | 1.50 | 13.8% | |
| EBITDA | 2.46B | 2.12B | 13.7% | |
| Gross Margin | 65.67% | 65.53% | 0.2% | |
| Operating Margin | 43.99% | 44.90% | 2.1% | |
| Net Income Margin | 32.98% | 24.21% | 26.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.72B | 1.46B | 2.90B | — | — |
| Gross Profit | 1.13B | 958.80M | 2.81B | — | — |
| Operating Income | 771.00M | 642.30M | 540.00M | — | — |
| Net Income | 415.70M | 481.50M | 356.00M | — | — |
| EPS | 1.50 | 1.74 | 1.28 | — | — |
| EBITDA | 2.12B | 2.46B | 2.38B | — | — |
| Gross Margin | 65.53% | 65.67% | 96.82% | — | — |
| Operating Margin | 44.90% | 43.99% | 18.63% | — | — |
| Net Income Margin | 24.21% | 32.98% | 12.28% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into TMXXF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics